Xeljanz recommended for FDA approval

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

New Member

Date Joined Jun 2017
Total Posts : 13
   Posted 3/8/2018 6:01 PM (GMT -6)   
The FDA's Gastrointestinal Drugs Advisory Committee voted 15 - 0 in favor of including a higher dosing regimen (10 mg twice daily) for Pfizer's (PFE +1.5%) XELJANZ (tofacitinib) for adult patients with moderately to severely active ulcerative colitis (UC) who have not responded adequately to corticosteroids, azathioprine, 6-mercaptopurine or tumor necrosis factor inhibitor therapy. Physicians will have the option of administering 5 mg or 10 mg twice daily for these patients.

The vote was split on the question of the need for a post-marketing efficacy study, 7 in favor and 8 opposed.

The FDA's action date is in June.


Forum Moderator

Date Joined Aug 2012
Total Posts : 13246
   Posted 3/8/2018 6:59 PM (GMT -6)   
Awesome, easier for us to get when it's officially approved for uc (rather than off-label).
Moderator Ulcerative Colitis
, 39, UC Proctosigmoiditis
Rx: Remicade @5mgs/kg/6wks; daily 75mgs 6MP, 4.8g generic-Lialda, and rowasa

UC experience: wakeup with noisy bowels so no lingering in bed, soon after poop with discomfort/pain/mild-nausea, eat something, poop, get dressed, poop, leave in car and worry whole drive about more...
New Topic Post Reply Printable Version
Forum Information
Currently it is Wednesday, September 26, 2018 12:28 AM (GMT -6)
There are a total of 3,006,706 posts in 329,381 threads.
View Active Threads

Who's Online
This forum has 161845 registered members. Please welcome our newest member, StanInCA.
156 Guest(s), 3 Registered Member(s) are currently online.  Details
borrelioburgdorferii, Serfr, Saipan Paradise